GABAPENTIN
- Product NDC
- 50436-0813
- 11-digit product format
- 504360813
- Labeler code
- 50436
- Product ID
- 50436-0813_89ec6ab3-4134-4a6d-89be-bcbd3913be1d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GABAPENTIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Unit Dose Services
- Application
- ANDA090705
- Marketing category
- ANDA
- Marketing start
- 2016-06-29
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 100 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 50436-0813-1 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-187d-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use, Initial U.S. Approval: 1993 |
| 50436-0813-2 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-187d-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use, Initial U.S. Approval: 1993 |
| 50436-0813-3 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-187d-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use, Initial U.S. Approval: 1993 |
| 50436-0813-4 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-187d-a910-e053-dadaa90a0b85 | These highlights do not include all the information needed to use GABAPENTIN CAPSULES safely and effectively. See full prescribing information for GABAPENTIN CAPSULES. GABAPENTIN capsules, for oral use, Initial U.S. Approval: 1993 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50436-0813-1 | GABAPENTIN | 30 in 1 BOTTLE | CAPSULE | 30 | | 4 |
| 50436-0813-2 | GABAPENTIN | 60 in 1 BOTTLE | CAPSULE | 60 | | 4 |
| 50436-0813-3 | GABAPENTIN | 90 in 1 BOTTLE | CAPSULE | 90 | | 4 |
| 50436-0813-4 | GABAPENTIN | 120 in 1 BOTTLE | CAPSULE | 120 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50436-0813 | GABAPENTIN CAPSULE [UNIT DOSE SERVICES] | 4 | Legacy NDC, 4 package rows | 20170811_1cee4f32-b1f6-4a8e-bcb1-64f4cdab7a2f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 50436-0813-1 | 50436081301 | 30 in 1 BOTTLE | Historical |
| 50436-0813-2 | 50436081302 | 60 in 1 BOTTLE | Historical |
| 50436-0813-3 | 50436081303 | 90 in 1 BOTTLE | Historical |
| 50436-0813-4 | 50436081304 | 120 in 1 BOTTLE | Historical |